CLINICAL_TRIALS
trial_result
· 2018-10-25
Clinical Trial Update: A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine [Phase 1]
Summary
A Phase 1 trial evaluated the interaction between LY2603618 and the metabolic pathway of desipramine; study completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-10-25